🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. CG Future Annuloplasty Ring/Band

    Rhythm Pharmaceuticals Netherlands B.V.

    Mitral Valve Insufficiency

    approved other completed

    1 trial
  2. COLECALCIFEROL , The Placebo product consists only of pure Ph. Eur. refined olive and it differs from Test product for the absence of active substance only: therefore, there are no reasons to suspect that the placebo product will undergo changes in its physical characteristics or degradation., Placebo

    Fondazione Telethon ETS

    obese elderly people with vitamin D deficiency

    approved small molecule active

    1 trial
  3. CRT

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial
  4. CRT + AOP

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial
  5. CRT-P or CRT-D Device

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure, Congestive

    approved other terminated

    1 trial
  6. Cannabidiol

    Jazz Pharmaceuticals Ireland Limited

    Lennox Gastaut Syndrome

    approved small molecule active

    1 trial
  7. Cannabidiol (Epidiolex)

    Jazz Pharmaceuticals Ireland Limited

    Study the Efficacy of Epidiolex for Typical Absence Seizures

    approved small molecule completed

    1 trial
  8. Cannabidiol Oral Solution [Epidiolex]

    Jazz Pharmaceuticals Ireland Limited

    Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

    approved small molecule completed

    1 trial
  9. CareLink Remote Monitoring

    Rhythm Pharmaceuticals Netherlands B.V.

    Pacemaker

    approved other completed

    1 trial
  10. Carvedilol NORMON 6.25 mg tablets EFG., Il n'a pas de substance active. Le produit est un comprimé pelliculé sécable blanc, de forme ovale, de longueur 8mm, avec une gravure F57 sur une face et une barre de sécabilité sur l’autre face. Excipients: Prosolv Easytab SP (Cellulose microcristalline, Silice colloïdale, Sodium starch glycolate, Sodium stéaryl fumarate). Solution de pelliculage: (Hypromellose, PEG 3350, Candurin silver sheen)

    Tour Hekla

    Asymptomatic Child-Pugh A5 to B8 cirrhosis

    approved small molecule active

    1 trial
  11. Ceftolozane/tazobactam

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Bronchiectasis

    approved small molecule active

    1 trial
  12. Cetrorelix Acetate

    United Therapeutics Europe Ltd

    Infertility

    approved small molecule active

    1 trial
  13. Conducted AF-Response Algorithm (CAFR) On

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other terminated

    1 trial
  14. Conivaptan

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    approved small molecule completed

    4 trials
  15. Crushed ticagrelor followed by morphine

    COLLEGIUM PHARMACEUTICAL, INC

    Unstable Angina Pectoris

    approved small molecule completed

    2 trials
  16. D-CURE 25000 UI gélules., Placebo of vitamin D

    Laboratoire HRA Pharma

    Periodontitis

    approved small molecule active

    1 trial
  17. DABIGATRAN ETEXILATE , CLOPIDOGREL , RIVAROXABAN , APIXABAN , ACENOCOUMAROL , EDOXABAN

    The George Institute

    patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment

    approved small molecule active

    1 trial
  18. DOAC

    Rhythm Pharmaceuticals Netherlands B.V.

    Ventricular Tachycardia

    approved small molecule completed

    1 trial
  19. DePuy ASR Hip System

    International Peace Maternity and Child Health Hospital

    Rheumatoid Arthritis

    approved other terminated

    1 trial
  20. Denominación Común Internacional (DCI): placebo (Suero fisiológico) Denominación Química: Cloruro Sódico 0.9% Forma molecular: NaCl Composición cuali y cuantitativa: 9mg/ml Forma farmacéutica: solución para pulverización nasal Dosis y vía de administración: 0.6ml/ día (6 pulverizaciones ) vía intranasa, Syntocinon 40 U.I./ml Solução para pulverização nasal

    The George Institute

    Borderline Personality Disorder.

    approved small molecule active

    1 trial
  21. Depo-Medroxyprogesterone Acetate

    United Therapeutics Europe Ltd

    HIV

    approved small molecule completed

    1 trial
  22. Desvenlafaxine Succinate

    Grace Therapeutics

    Vascular Depression

    approved small molecule active

    1 trial
  23. Dexamethasone

    The University of Hong Kong

    Total Knee Replacement

    approved small molecule active

    1 trial
  24. Dexamethasone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Localized Primary Osteoarthritis of Both Hips (Diagnosis)

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources